Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...
Compugen Ltd. (NASDAQ:CGEN – Get Rating) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest totalling 1,690,000 shares, a decline of 7.1% from the May 15th total of 1,820,000 shares. Based on an average trading volume of 399,500 shares, the days-to-cover […]
Compugen Ltd. (NASDAQ:CGEN – Get Rating) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 1,690,000 shares, a decrease of 7.1% from the May 15th total of 1,820,000 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an […]
Compugen Ltd. (NASDAQ:CGEN – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 1,690,000 shares, a drop of 7.1% from the May 15th total of 1,820,000 shares. Based on an average daily volume of 399,500 shares, the short-interest […]
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery,...